Canonical ingredient

Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, hydrochloride, (5?)-

OXYCODONE HYDROCHLORIDE

90 linked products

Official identifiers

CAS 124-90-3 ChEBI CHEBI:7859 InChI InChI=1S/C18H21NO4.ClH/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10;/h3-4,13,16,21H,5-9H2,1-2H3;1H/t13-,16+,17+,18-;/m1./s1 InChIKey MUZQPDBAOYKNLO-RKXJKUSZSA-N KEGG_COMPOUND C08026 SMILES COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314.Cl

Names and synonyms

Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, hydrochloride, (5?)- (en)
oxycodone hydrochloride (en)
Chlorhydrate d'oxycodone (fr)
Morphinan-6-one, 4,5-époxy-14-hydroxy-3-méthoxy-17-méthyl-, chlorhydrate, (5?)- (fr-CA)

Source-scoped chemical properties

Every value keeps its own authority, licence and retrieval date. Conflicting values are not silently merged.

canada dsl listing: listed; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl bioaccumulative: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl inherently toxic aquatic: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl meets cepa categorization: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl meets environmental: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl meets human health: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl persistent: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl substance category: Organics; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03

Safety and technical documents

General references and manufacturer-specific SDS documents are kept separate.

0 document(s)

No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.

End-to-end traceability

Only links supported by an identified source are published. Missing evidence remains explicitly unknown.

Partial chain

Evidence still missing

Country or region of origin
Raw-material producer
Ingredient manufacturer
Distributor
Transformation steps

Documented origins

No origin has been proven yet by an explicit source.

Documented organizations

No organization has been proven yet by an explicit source.

Documented transformations

No transformation step has been proven yet by an explicit source.

Method: a company’s registration country is never used as evidence of a material’s origin.

Products containing this ingredient

ACT OXYCODONE CR

ACT OXYCODONE CR

ACT OXYCODONE CR

ACT OXYCODONE CR

ACT OXYCODONE CR

APO-OXYCODONE CR

APO-OXYCODONE CR

APO-OXYCODONE CR

APO-OXYCODONE CR

APO-OXYCODONE CR

APO-OXYCODONE CR

APO-OXYCODONE CR

APO-OXYCODONE CR

APO-OXYCODONE/ACET

NTP-OXYCODONE ACETAMINOPHEN

OXYCODONE/ACETAMINOPHEN